|
.ALPHA.1-PROTEINASE INHIBITOR HUMAN 1000 mg/20mL INJECTION
Patheon · NDC 63552-0187-00 · 48 VIAL, SINGLE-DOSE in 1 CASE (63552-187-00) / 20 mL in 1 VIAL, SINGLE-DOSE |
63552-0187-00 |
— |
On market |
View → |
|
.ALPHA.1-PROTEINASE INHIBITOR HUMAN 4000 mg/76mL INJECTION
Patheon · NDC 63552-0210-00 · 20 VIAL, SINGLE-DOSE in 1 CASE (63552-210-00) / 76 mL in 1 VIAL, SINGLE-DOSE |
63552-0210-00 |
— |
On market |
View → |
|
.ALPHA.1-PROTEINASE INHIBITOR HUMAN 5000 mg/95mL INJECTION
Patheon · NDC 63552-0213-00 · 20 VIAL, SINGLE-DOSE in 1 CASE (63552-213-00) / 95 mL in 1 VIAL, SINGLE-DOSE |
63552-0213-00 |
— |
On market |
View → |
|
ACETAZOLAMIDE SODIUM 500 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0116-99 · 99 VIAL in 1 CASE (63552-116-99) / 10 mL in 1 VIAL |
63552-0116-99 |
— |
On market |
View → |
|
AFLIBERCEPT-JBVF 40 mg/mL INJECTION
Patheon · NDC 63552-0281-00 · 208 VIAL in 1 CASE (63552-281-00) / .05 mL in 1 VIAL |
63552-0281-00 |
— |
On market |
View → |
|
ALTEPLASE 2.2 mg/2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0041-99 · 99 VIAL in 1 TRAY (63552-041-99) / 6 mL in 1 VIAL |
63552-0041-99 |
— |
On market |
View → |
|
ANAGRELIDE HYDROCHLORIDE .5 mg/1 CAPSULE
Patheon · NDC 63552-0005-01 · 192 BOTTLE, PLASTIC in 1 CASE (63552-005-01) / 100 CAPSULE in 1 BOTTLE, PLASTIC |
63552-0005-01 |
— |
On market |
View → |
|
asparaginase erwinia chrysanthemi (recombinant)-rywn 20 mg/mL INJECTION
Patheon · NDC 63552-0285-00 · 208 VIAL, SINGLE-DOSE in 1 CASE (63552-285-00) / .5 mL in 1 VIAL, SINGLE-DOSE |
63552-0285-00 |
— |
On market |
View → |
|
bevacizumab 100 mg/4mL INJECTION, SOLUTION
Patheon · NDC 63552-0113-00 · 77 VIAL in 1 CASE (63552-113-00) / 4 mL in 1 VIAL |
63552-0113-00 |
— |
On market |
View → |
|
bevacizumab 400 mg/16mL INJECTION, SOLUTION
Patheon · NDC 63552-0114-00 · 80 VIAL in 1 CASE (63552-114-00) / 16 mL in 1 VIAL |
63552-0114-00 |
— |
On market |
View → |
|
CARBAMAZEPINE 200 mg/1 TABLET
Patheon · NDC 63552-0060-05 · 72 BOTTLE in 1 CASE (63552-060-05) / 100 TABLET in 1 BOTTLE |
63552-0060-05 |
— |
On market |
View → |
|
Carfilzomib 60 mg/30mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0009-01 · 48 VIAL, GLASS in 1 CASE (63552-009-01) / 50 mL in 1 VIAL, GLASS |
63552-0009-01 |
— |
On market |
View → |
|
Carfilzomib 30 mg/15mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0035-00 · 81 VIAL in 1 CASE (63552-035-00) / 30 mL in 1 VIAL |
63552-0035-00 |
— |
On market |
View → |
|
Carfilzomib 10 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0214-00 · 72 VIAL in 1 CASE (63552-214-00) / 10 mL in 1 VIAL |
63552-0214-00 |
— |
On market |
View → |
|
clesrovimab 150 mg/mL INJECTION, SOLUTION
Patheon · NDC 63552-0269-00 · .7 mL in 1 SYRINGE, GLASS (63552-269-00) |
63552-0269-00 |
— |
On market |
View → |
|
COLISTIMETHATE SODIUM 150 mg/6mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0010-01 · 288 VIAL, GLASS in 1 CASE (63552-010-01) / 6 mL in 1 VIAL, GLASS |
63552-0010-01 |
— |
On market |
View → |
|
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 CAPSULE, EXTENDED RELEASE
Patheon · NDC 63552-0130-00 · 36000 CAPSULE, EXTENDED RELEASE in 1 DRUM (63552-130-00) |
63552-0130-00 |
— |
On market |
View → |
|
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 CAPSULE, EXTENDED RELEASE
Patheon · NDC 63552-0129-00 · 52000 CAPSULE, EXTENDED RELEASE in 1 DRUM (63552-129-00) |
63552-0129-00 |
— |
On market |
View → |
|
EPHEDRINE SULFATE 50 mg/mL INJECTION
Patheon · NDC 63552-0282-00 · 208 VIAL, SINGLE-DOSE in 1 CASE (63552-282-00) / 1 mL in 1 VIAL, SINGLE-DOSE |
63552-0282-00 |
— |
On market |
View → |
|
eravacycline dihydrochloride 50 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0218-00 · 120 VIAL in 1 CASE (63552-218-00) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
63552-0218-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 2000 [iU]/mL SOLUTION
Patheon · NDC 63552-0135-00 · 621 VIAL in 1 TRAY (63552-135-00) / 3 mL in 1 VIAL |
63552-0135-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 3000 [iU]/mL SOLUTION
Patheon · NDC 63552-0136-00 · 621 VIAL in 1 TRAY (63552-136-00) / 3 mL in 1 VIAL |
63552-0136-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 10000 [iU]/mL SOLUTION
Patheon · NDC 63552-0139-00 · 621 VIAL in 1 TRAY (63552-139-00) / 3 mL in 1 VIAL |
63552-0139-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 40000 [iU]/mL SOLUTION
Patheon · NDC 63552-0141-00 · 621 VIAL in 1 TRAY (63552-141-00) / 3 mL in 1 VIAL |
63552-0141-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 4000 [iU]/mL SOLUTION
Patheon · NDC 63552-0137-00 · 621 VIAL in 1 TRAY (63552-137-00) / 3 mL in 1 VIAL |
63552-0137-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 10000 [iU]/mL SOLUTION
Patheon · NDC 63552-0138-00 · 621 VIAL in 1 TRAY (63552-138-00) / 3 mL in 1 VIAL |
63552-0138-00 |
— |
On market |
View → |
|
ERYTHROPOIETIN 20000 [iU]/mL SOLUTION
Patheon · NDC 63552-0140-00 · 621 VIAL in 1 TRAY (63552-140-00) / 3 mL in 1 VIAL |
63552-0140-00 |
— |
On market |
View → |
|
ETANERCEPT, LICENSE HOLDER UNSPECIFIED 25 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Patheon · NDC 63552-0102-00 · 5 TRAY in 1 CASE (63552-102-00) / 221 VIAL in 1 TRAY / 2 mL in 1 VIAL |
63552-0102-00 |
— |
On market |
View → |
|
ETELCALCETIDE HYDROCHLORIDE 5 mg/mL SOLUTION
Patheon · NDC 63552-0030-00 · 621 VIAL in 1 TRAY (63552-030-00) / 3 mL in 1 VIAL |
63552-0030-00 |
— |
On market |
View → |
|
ETELCALCETIDE HYDROCHLORIDE 2.5 mg/.5mL SOLUTION
Patheon · NDC 63552-0029-00 · 621 VIAL in 1 TRAY (63552-029-00) / 3 mL in 1 VIAL |
63552-0029-00 |
— |
On market |
View → |